West Nile Detect IgM Capture ELISA - FDA cleared
go back to news archives
InBios' West Nile Detect IgM Capture ELISA is for the qualitative presumptive detection of IgM antibodies to WNV recombinant antigens (WNRA) in serum as an aid in the clinical laboratory diagnosis of West Nile virus infection in patients with clinical symptoms consistent with encephalitis/meningitis.
Positive results must be confirmed by Plaque Reduction Neutralization Test (PRNT), or by using the current CDC guidelines for diagnosis of this disease.
Features Sensitivity and specificity > 95%. Easy to follow protocol. Results in 4 hours or less. Excellent correlation with PRNT and CDC ELISA
NOTE: This item is from our 'historic' database and
may contain information which is not up to date.
Source : InBios International Inc. View Company Information
Posted on February 21, 2005
LATEST MICROBIOLOGY NEWS
MICROBIOLOGY EVENTS
-
USP Chapter <86> and the Move to Recombinant Methods
29 Apr 2025 -
2025 Novogene Sequencing Symposium
8 May 2025 -
Explore the Future of Sterility Testing with Rapid Micro Biosystems®
14 May 2025 -
Understanding USP <73> to Accelerate Sterility Testing for Short-Life Products
14 May 2025 -
British Society For Microbial Technology 40th Anniversary Microbiology Conference
15 May 2025 -
How Is VIDAS® KUBE™ Transforming Food Pathogen Detection?
19 May 2025 -
Sampling and Microbial Testing of Water and Data Trending
20 May 2025 -
European Microbiology Conference and Workshop 2025
20 May 2025 -
Future Labs Live 2025
27 May 2025 -
2025 Endotoxin Testing Summit
10 Jun 2025